GLP-1 drugs like Zepbound and Wegovy are often touted as the greatest thing since sliced bread, with research suggesting that they can help with weight loss, type 2 diabetes, and heart disease, and possibly even reduce the risk of both dementia and addiction
Eating slowly, with more chewing and smaller bites, leads to more pronounced GLP-1 release and greater feelings of fullness
Weight regain after discontinuing GLP-1 medications is real and documented the STEP 4 trial showed meaningful regain after stopping semaglutide
Understanding the whole patient prior to receiving transplant and cellular therapy: Real-world data on patients financial toxicity prior to receiving treatment Miranda Kapfhammer 1 , Rachel Cusatis 1 , Deborah Mattila 2 , Sarah Smith 2 1 Medical College of Wisconsin, Milwaukee, USA, 2 National Marrow Donor Program (NMDP), Minneapolis, USA Aims Cellular therapy (CT) recipients are at high risk for financial toxicity (FT) given the frequent need for temporary re-location, loss of income for patients and caregivers in addition to the expected medical expenses of cancer care
